Showing results (141-150 of 163) with videos related to
Sort By:
Pageof 17
Journal of Virology|October 19, 2007
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infectionS Munir Alam, Richard M Scearce, Robert J Parks, et al.JCI Insight|March 9, 2018
Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding siteHao D Cheng, Sebastian K Grimm, Morgan Sa Gilman, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 5, 2006
Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypesSurender Khurana, James Needham, Susan Park, et al.Frontiers in Immunology|May 30, 2019
Immune Correlates of Disease Progression in Linked HIV-1 InfectionMichael Tuen, Jude S Bimela, Andrew N Banin, et al.Plos One|January 26, 2013
Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trialSusan Zolla-Pazner, Allan C deCamp, Timothy Cardozo, et al.Plos One|February 8, 2014
Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infectionSusan Zolla-Pazner, Allan deCamp, Peter B Gilbert, et al.Plos One|October 3, 2013
Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trialRaphael Gottardo, Robert T Bailer, Bette T Korber, et al.Science Translational Medicine|July 17, 2015
HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisitionHeather A Prentice, Georgia D Tomaras, Daniel E Geraghty, et al.Nature Communications|October 22, 2024
Loss of HIV candidate vaccine efficacy in male macaques by mucosal nanoparticle immunization rescued by V2-specific responseMohammad Arif Rahman, Massimiliano Bissa, Hanna Scinto, et al.Journal of Virology|November 24, 2012
Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletionS Munir Alam, Hua-Xin Liao, Georgia D Tomaras, et al.Pageof 17